Kevin Prussia is an experienced trial lawyer with signiﬁcant experience representing leading life sciences and technology companies in major disputes involving intellectual property and commercial matters.
Prussia is a true “stand-up” litigator who has handled challenging witness examinations and oral arguments for clients in high-stakes litigations. His recent engagements include a win as co-lead trial counsel on behalf of a Fortune 500 company in a patent case involving a several-billion-dollar-a-year product.
Prussia was also recently recognized by The American Lawyer for a summary judgment win on behalf of a Fortune 500 company in a case involving one of the top-selling video game franchises of all time.
Prussia has a deep pro bono practice at the ﬁrm, having received the Civil Rights Pro Bono Recognition Award from the Lawyers’ Committee in 2013. Prussia is a member of the ﬁrm’s global Management, Compensation, and Diversity Committees.
Prussia was recognized as a 2019 US Rising Star in IP by LMG Life Sciences and was named a “Future Star” in Massachusetts by Benchmark Litigation in 2022.